BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 35674738)

  • 21. (68)Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma.
    Lapa C; Lückerath K; Kleinlein I; Monoranu CM; Linsenmann T; Kessler AF; Rudelius M; Kropf S; Buck AK; Ernestus RI; Wester HJ; Löhr M; Herrmann K
    Theranostics; 2016; 6(3):428-34. PubMed ID: 26909116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CXCR4-directed theranostics in oncology and inflammation.
    Kircher M; Herhaus P; Schottelius M; Buck AK; Werner RA; Wester HJ; Keller U; Lapa C
    Ann Nucl Med; 2018 Oct; 32(8):503-511. PubMed ID: 30105558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual Targeting of Acute Leukemia and Supporting Niche by CXCR4-Directed Theranostics.
    Habringer S; Lapa C; Herhaus P; Schottelius M; Istvanffy R; Steiger K; Slotta-Huspenina J; Schirbel A; Hänscheid H; Kircher S; Buck AK; Götze K; Vick B; Jeremias I; Schwaiger M; Peschel C; Oostendorp R; Wester HJ; Grigoleit GU; Keller U
    Theranostics; 2018; 8(2):369-383. PubMed ID: 29290814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective non-invasive evaluation of CXCR4 expression for the diagnosis of MALT lymphoma using [
    Haug AR; Leisser A; Wadsak W; Mitterhauser M; Pfaff S; Kropf S; Wester HJ; Hacker M; Hartenbach M; Kiesewetter-Wiederkehr B; Raderer M; Mayerhoefer ME
    Theranostics; 2019; 9(12):3653-3658. PubMed ID: 31281504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CXCR4-Directed PET/CT with [
    Chen Z; Yang A; Zhang J; Chen A; Zhang Y; Huang C; Chen S; Yao S; Miao W
    Mol Imaging Biol; 2022 Jun; 24(3):416-424. PubMed ID: 34651291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pentixafor PET/CT for imaging of chemokine receptor 4 expression in esophageal cancer - a first clinical approach.
    Linde P; Baues C; Wegen S; Trommer M; Quaas A; Rosenbrock J; Celik E; Marnitz S; Bruns CJ; Fischer T; Schomaecker K; Wester HJ; Drzezga A; van Heek L; Kobe C
    Cancer Imaging; 2021 Feb; 21(1):22. PubMed ID: 33579381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [
    Lau J; Kwon D; Rousseau E; Zhang Z; Zeisler J; Uribe CF; Kuo HT; Zhang C; Lin KS; Bénard F
    Mol Pharm; 2019 Nov; 16(11):4688-4695. PubMed ID: 31545614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [68Ga]Pentixafor-PET/CT for imaging of chemokine receptor 4 expression in small cell lung cancer--initial experience.
    Lapa C; Lückerath K; Rudelius M; Schmid JS; Schoene A; Schirbel A; Samnick S; Pelzer T; Buck AK; Kropf S; Wester HJ; Herrmann K
    Oncotarget; 2016 Feb; 7(8):9288-95. PubMed ID: 26843617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response assessment with the CXCR4-directed positron emission tomography tracer [
    Herhaus P; Habringer S; Vag T; Steiger K; Slotta-Huspenina J; Gerngroß C; Wiestler B; Wester HJ; Schwaiger M; Keller U
    EJNMMI Res; 2017 Dec; 7(1):51. PubMed ID: 28577295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CXCR4-Targeted PET Imaging of Central Nervous System B-Cell Lymphoma.
    Herhaus P; Lipkova J; Lammer F; Yakushev I; Vag T; Slotta-Huspenina J; Habringer S; Lapa C; Pukrop T; Hellwig D; Wiestler B; Buck AK; Deckert M; Wester HJ; Bassermann F; Schwaiger M; Weber W; Menze B; Keller U
    J Nucl Med; 2020 Dec; 61(12):1765-1771. PubMed ID: 32332145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical detection of chemokine receptor 4 expression in chronic osteomyelitis confirms specific uptake in 68Ga-Pentixafor-PET/CT.
    Bouter Y; Meller B; Sahlmann CO; Wolf BJ; Langer L; Bankstahl JP; Wester HJ; Kropf S; Meller J; Bouter C
    Nuklearmedizin; 2018 Sep; 57(5):198-203. PubMed ID: 30267402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imaging Inflammation in Atherosclerosis with CXCR4-Directed
    Kircher M; Tran-Gia J; Kemmer L; Zhang X; Schirbel A; Werner RA; Buck AK; Wester HJ; Hacker M; Lapa C; Li X
    J Nucl Med; 2020 May; 61(5):751-756. PubMed ID: 31653710
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Watts A; Singh B; Singh H; Kaur H; Bal A; Vohra M; Arora SK; Behera D
    J Nucl Med Technol; 2022 Sep; 50(3):278-281. PubMed ID: 35610039
    [No Abstract]   [Full Text] [Related]  

  • 34. Imaging Aldosterone-Producing Adrenocortical Carcinoma With 68 Ga-Pentixafor PET/CT.
    Shu Q; Deng M; Chen Y; Liu N; Cai L
    Clin Nucl Med; 2022 Aug; 47(8):e572-e573. PubMed ID: 35426842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C-X-C Motif Chemokine Receptor 4-Targeted Radioligand Therapy in Patients with Advanced T-Cell Lymphoma.
    Buck AK; Grigoleit GU; Kraus S; Schirbel A; Heinsch M; Dreher N; Higuchi T; Lapa C; Hänscheid H; Samnick S; Einsele H; Serfling SE; Werner RA
    J Nucl Med; 2023 Jan; 64(1):34-39. PubMed ID: 35738903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of CXCR4-Directed PET/CT on Staging and Proposed Oncologic Management in Patients With Digestive System Tumors.
    Weich A; Serfling SE; Schlötelburg W; Higuchi T; Hartrampf PE; Schirbel A; Heinrich M; Buck AK; Rowe SP; Kosmala A; Werner RA
    Clin Nucl Med; 2023 Jul; 48(7):586-593. PubMed ID: 37167408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CXCR4 Expression Demonstrated by 68Ga-Pentixafor PET/CT Imaging in a Case of Systemic Mastocytosis Mimicking Lymphoma.
    Kiran MY; Apaydin Arikan E; Sanli Y; Yegen G; Kuyumcu S
    Clin Nucl Med; 2021 Dec; 46(12):e563-e564. PubMed ID: 34269725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biodistribution and radiation dosimetry for the chemokine receptor CXCR4-targeting probe 68Ga-pentixafor.
    Herrmann K; Lapa C; Wester HJ; Schottelius M; Schiepers C; Eberlein U; Bluemel C; Keller U; Knop S; Kropf S; Schirbel A; Buck AK; Lassmann M
    J Nucl Med; 2015 Mar; 56(3):410-6. PubMed ID: 25698782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging.
    Wester HJ; Keller U; Schottelius M; Beer A; Philipp-Abbrederis K; Hoffmann F; Šimeček J; Gerngross C; Lassmann M; Herrmann K; Pellegata N; Rudelius M; Kessler H; Schwaiger M
    Theranostics; 2015; 5(6):618-30. PubMed ID: 25825601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting CXCR4 with [
    Lapa C; Kircher S; Schirbel A; Rosenwald A; Kropf S; Pelzer T; Walles T; Buck AK; Weber WA; Wester HJ; Herrmann K; Lückerath K
    Oncotarget; 2017 Nov; 8(57):96732-96737. PubMed ID: 29228566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.